Drug Profile
Retrogen
Latest Information Update: 16 Nov 1994
Price :
$50
*
At a glance
- Originator Retrogen Medical
- Class Antivirals
- Mechanism of Action RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 16 Nov 1994 No-Development-Reported for HIV infections treatment in USA (Unknown route)